Pre-Open Movers: DocuSign, Zscaler Jumps Post EPS; Allakos Falls on Drug Data

This post was originally published on this site

https://i-invdn-com.investing.com/news/LYNXMPEABP0E4_M.jpg

Digital Media Solutions Inc (NYSE:DMS) 62% HIGHER; announced that its board of directors has received an offer from Prism Data, LLC, an investment vehicle affiliated with CEO Joseph Marinucci and COO Fernando Borghese, to acquire all of the outstanding Class A common stock of DMS for $2.50 per share in cash.

DocuSign Inc. (NASDAQ:DOCU) 18% HIGHER; reported Q2 EPS of $0.44, $0.02 better than the analyst estimate of $0.42. Revenue for the quarter came in at $622.2 million versus the consensus estimate of $602 million. DocuSign sees FY2022 revenue of $2.470-2.482 billion, versus the consensus of $2.47 billion. DocuSign sees Q3 2022 revenue of $624-628 million, versus the consensus of $625 million.

Swvl Holdings Corp (NASDAQ:SWVL13% HIGHER; Baird initiates coverage with an Outperform rating and a price target of $8.00.

Allakos (NASDAQ:ALLK13% LOWER; reported data from EoDyssey, a 24-week, Phase 3, randomized, double-blind, placebo-controlled study of lirentelimab in patients with biopsy confirmed eosinophilic duodenitis (EoD). The trial met its histologic co-primary endpoint, but it did not achieve statistical significance on the patient reported symptomatic co-primary endpoint, in both the intent to treat population and in a prespecified subpopulation.

Zscaler (NASDAQ:ZS) 13% HIGHER; reported Q4 EPS of $0.25, $0.04 better than the analyst estimate of $0.21. Revenue for the quarter came in at $318.1 million versus the consensus estimate of $305.43 million. Zscaler sees Q1 2023 EPS of $0.26. Zscaler sees Q1 2023 revenue of $339-341 million, versus the consensus of $324.8 million. Zscaler sees FY2023 EPS of $1.16-$1.18. Zscaler sees FY2023 revenue of $1.49-1.5 billion, versus the consensus of $1.47 billion

Zumiez, Inc. (NASDAQ:ZUMZ) 11% LOWER; reported Q2 EPS of $0.16, $0.31 worse than the analyst estimate of $0.47. Revenue for the quarter came in at $220 million versus the consensus estimate of $232.71 million. Zumiez, Inc. sees Q3 2022 EPS of $0.03-$0.18, versus the consensus of $1.13. Zumiez, Inc. sees Q3 2022 revenue of $220-228 million, versus the consensus of $278.62 million.

Riot Blockchain, Inc. (NASDAQ:RIOT) 9% HIGHER; Bitcoin moves above $21K.

Marathon Digital Holdings Inc (NASDAQ:MARA9% HIGHER; Bitcoin moves above $21K.

MicroStrategy Incorporated (NASDAQ:MSTR) 8% HIGHER; Bitcoin moves above $21K.

Coinbase (NASDAQ:COIN) 8% HIGHER; Bitcoin moves above $21K, upgraded at Daiwa.

R1 RCM Inc. (NASDAQ:RCM) 7% LOWER; announced the commencement of an underwritten public offering of 15,000,000 shares of its common stock by TCP-ASC ACHI Series LLLP.

Limoneira Co (NASDAQ:LMNR) 6% HIGHER; reported Q3 EPS of $0.41, $0.17 better than the analyst estimate of $0.24. Revenue for the quarter came in at $58.9 million versus the consensus estimate of $51.39 million.

American Outdoor Brands (NASDAQ:AOUT) 6% LOWER; reported Q2 EPS of $0.01, $0.06 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $43.7 million versus the consensus estimate of $44.48 million.

National Beverage (NASDAQ:FIZZ) 5% LOWER; reported Q2 EPS of $0.38, $0.14 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $318.1 million versus the consensus estimate of $331.97 million.

Smith & Wesson Brands Inc (NASDAQ:SWBI) 4% LOWER; reported Q1 EPS of $0.11, $0.46 worse than the analyst estimate of $0.57. Revenue for the quarter came in at $190.2 million versus the consensus estimate of $167.68 million.

Mission Produce Inc (NASDAQ:AVO) 3% LOWER; reported Q3 EPS of $0.27, $0.03 worse than the analyst estimate of $0.30. Revenue for the quarter came in at $313.2 million versus the consensus estimate of $292.93 million.

Lincoln Educational Services (NASDAQ:LINC) 2% HIGHER; Rosenblatt initiates coverage with a Buy rating and a price target of $8.00.

Valaris Ltd (NYSE:VAL) 2% HIGHER; announced that its Board of Directors has authorized a share repurchase program under which the company may purchase up to $100 million of Valaris’ outstanding common stock.

Waldencast Acquisition Corp (NASDAQ:WALD1% HIGHER; DA Davidson initiates coverage on with a Buy rating and a price target of $12.00.

RH (NYSE:RH) 1% HIGHER; reported Q2 EPS of $8.08, $1.45 better than the analyst estimate of $6.63. Revenue for the quarter came in at $992 million versus the consensus estimate of $968.91 million.

Add Comment